SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001047469-18-006977
Filing Date
2018-11-01
Accepted
2018-11-01 17:01:55
Documents
6
Period of Report
2018-10-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2237038z8-k.htm 8-K 37516
2 EX-2.1 a2237038zex-2_1.htm EX-2.1 32351
3 EX-10.1 a2237038zex-10_1.htm EX-10.1 130967
4 EX-10.2 a2237038zex-10_2.htm EX-10.2 83490
5 EX-99.1 a2237038zex-99_1.htm EX-99.1 26010
6 G1892810MMI001.JPG g1892810mmi001.jpg GRAPHIC 7638
  Complete submission text file 0001047469-18-006977.txt   322226
Mailing Address 9 FOURTH AVE WALTHAM MA 02451
Business Address 9 FOURTH AVE WALTHAM MA 02451 617-500-2802
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 181154643
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1